ArticleAAPS PharmSciTech2025
Correction: In Vivo Evaluation of Almotriptan Malate Formulation Through Intranasal Route for the Treatment of Migraine: Systematic Development and Pharmacokinetic Assessment.
Shubham Gupta et al.PubMed ↗Publisher ↗
No numbers read from the abstract.